Cinven enters exclusive negotiations to acquire clinical nutrition specialist Nutrisens, with a focus on growth through innovation and strategic expansion.
Information on the Target
The Nutrisens group, established in 2011 by Georges Devesa, is a premier clinical nutrition specialist headquartered in Chaponost, France. The company is dedicated to developing, manufacturing, and distributing a diverse portfolio of clinical nutrition products that address a variety of medical conditions including malnutrition, dysphagia, weight loss, and muscle wasting. Nutrisens particularly focuses on vulnerable populations, notably the elderly, ensuring they receive essential nutritional support.
In recent years, Nutrisens has significantly expanded its international presence, now operating subsidiaries in Brazil, Spain, Italy, the UK, Germany, and Portugal. With a footprint in over 30 countries and a workforce exceeding 750 employees, the company's commitment to innovation and quality sets it apart in the industry. Nutrisens collaborates with healthcare professionals, dieticians, chefs, and researchers to ensure their offerings are not only nutritionally effective but also appealing to patients.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in France
France’s medical nutrition market is experiencing robust growth, driven by demographic trends such as an aging population and increasing awareness about the importance of clinical nutrition. As the demand for nutritional solutions
Similar Deals
SK Capital Partners → LISI Group's Medical division
2025
Asker Healthcare Group → Finmed SAS
2025
Cinven
invested in
Nutrisens group
in 2025
in a Buyout deal